← FDA Drug Approvals (Drugs@FDA)

CITALOPRAM HYDROBROMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2006-06-14

Drug application

FDA Application #

ANDA077629

Application type

Abbreviated New Drug Application (Generic)

Brand name

CITALOPRAM HYDROBROMIDE

Generic name

CITALOPRAM

Active ingredients

CITALOPRAM HYDROBROMIDE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

CHARTWELL MOLECULAR

Manufacturer

Chartwell Governmental & Specialty RX, LLC.

First approval

2006-06-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown